Patents by Inventor Gary Bright

Gary Bright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8788213
    Abstract: Disclosed herein are methods and devices for sectioning cell colonies. Also disclosed are methods of purifying cell colonies. A method of sectioning cell colonies can include providing a cell colony on a culture plate comprising a known thickness; positioning a bottom of the culture plate using automated focus technology; and sectioning the cell colony into one or more pieces using a pattern of laser cutting lines. Devices for performing the method are also disclosed.
    Type: Grant
    Filed: January 12, 2010
    Date of Patent: July 22, 2014
    Assignee: Intrexon Corporation
    Inventors: Gary Bright, Kristi Hohenstein, Anuradha Soundararajan, Manfred Koller
  • Publication number: 20100184119
    Abstract: Disclosed herein are methods and devices for sectioning cell colonies. Also disclosed are methods of purifying cell colonies. A method of sectioning cell colonies can include providing a cell colony on a culture plate comprising a known thickness; positioning a bottom of the culture plate using automated focus technology; and sectioning the cell colony into one or more pieces using a pattern of laser cutting lines. Devices for performing the method are also disclosed.
    Type: Application
    Filed: January 12, 2010
    Publication date: July 22, 2010
    Inventors: Gary Bright, Kristi Hohenstein, Anuradha Soundararajan, Manfred Koller
  • Publication number: 20100179310
    Abstract: Some aspects relate to methods for genetic analysis of selected cells from within a heterogeneous population of cells. The population of cells first can be partitioned. Selected cells are identified by imaging, and then specifically targeted and lysed by irradiation with an energy beam, resulting in specific release of their cellular contents into the culture medium. The culture medium then can be sampled and assayed for the desired nucleic acids.
    Type: Application
    Filed: January 8, 2010
    Publication date: July 15, 2010
    Applicant: Cyntellect, Inc.
    Inventors: Fredrik Kamme, Gary Bright, Gustaf Angelborg, James Linton, Manfred Koller
  • Patent number: 7244614
    Abstract: The present invention provides novel recombinant fusion proteins for detecting binding of a molecule of interest containing a detection domain, a first and optionally a second localization domain, and a binding domain. The invention also provides recombinant nucleic acid molecules and recombinant expression vectors encoding these novel fusion proteins, genetically engineered host cells containing these expression vectors, and kits for the use of these fusion proteins, nucleic acid molecules, expression vectors, and host cells. Additionally, the present invention provides methods for identifying compounds that alter the binding of a molecule of interest in a cell.
    Type: Grant
    Filed: August 1, 2002
    Date of Patent: July 17, 2007
    Assignee: Cellomics, Inc.
    Inventors: Gary Bright, Daniel Rajadavid Premkumar, Yih-Tai Chen
  • Publication number: 20060094868
    Abstract: The present invention provides systems, methods, screens, reagents and kits for optical system analysis of cells to rapidly determine the distribution, environment, or activity of fluorescently labeled reporter molecules in cells for the purpose of screening large numbers of compounds for those that specifically affect particular biological functions.
    Type: Application
    Filed: October 17, 2005
    Publication date: May 4, 2006
    Inventors: Kenneth Giuliano, Gary Bright, Keith Olson, Sarah Burroughs-Tencza
  • Patent number: 6756207
    Abstract: The present invention provides systems, methods, screens, reagents and kits for optical system analysis of cells to rapidly determine the distribution, environment, or activity of fluorescently labeled reporter molecules in cells for the purpose of screening large numbers of compounds for those that specifically affect particular biological functions.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: June 29, 2004
    Assignee: Cellomics, Inc.
    Inventors: Kenneth A. Giuliano, Gary Bright, Keith Olson, Sarah Burroughs Tencza
  • Publication number: 20030104479
    Abstract: The present invention provides novel recombinant fusion proteins for detecting binding of a molecule of interest containing a detection domain, a first and optionally a second localization domain, and a binding domain. The invention also provides recombinant nucleic acid molecules and recombinant expression vectors encoding these novel fusion proteins, genetically engineered host cells containing these expression vectors, and kits for the use of these fusion proteins, nucleic acid molecules, expression vectors, and host cells. Additionally, the present invention provides methods for identifying compounds that alter the binding of a molecule of interest in a cell.
    Type: Application
    Filed: August 1, 2002
    Publication date: June 5, 2003
    Applicant: Cellomics, Inc.
    Inventors: Gary Bright, Daniel Rajadavid Premkumar, Yih-Tai Chen